3 not yet recruiting, 1 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Not yet recruiting 3, Recruiting 1 |
Follow Lei Liu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Chemotherapy + PD-1 Inhibitor+Different Radiotherapy Fractionations for HR+/HER2- Breast Cancer Chemotherapy+PD-1 inhibitor+8Gy x 3f, Chemotherapy+PD-1 inhibitor+16Gy x 1f, Chemotherapy+PD-1 inhibitor+2.67Gy x 15f - HR+HER2- Breast Cancer | Phase 2 | Not yet recruiting | Lei Liu | 60 | 2024-11-01 | 2024-10-15 |
| A Phase II Study of MRG003 Injection Combined With Pucotenlimab Injection ± Cisplatin Injection in the Neoadjuvant Treatment Locally Advanced EGFR-positive Head and Neck Squamous Cell Carcinoma MRG003 combined with Pucotenlimab, MRG003 combined with Pucotenlimab+Cisplatin - Head and Neck Squamous Cell Carcinoma (HNSCC) | Phase 2 | Not yet recruiting | Lei Liu | 30 | 2024-08-01 | 2024-07-31 |
| A Phase II Study of Anti-EGFR Antibody-drug Conjugate (ADC) Combine With CDK4/6 Inhibitors Posterior Line in the Treatment of Recurrent/Metastatic CDKN2A Gene Variant Head and Neck Squamous Cell Carcinoma MRG003 combined with Dalpicicilip - Head and Neck Squamous Cell Carcinoma | Phase 2 | Not yet recruiting | Lei Liu | 30 | 2024-08-01 | 2024-07-19 |
| A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma Ivonescimab combined with TP, Cadonilimab combined with TP, Penpulimab combined with TP - Head and Neck Squamous Cell Carcinoma | Phase 2 | Recruiting | Lei Liu | 90 | 2024-07-01 | 2024-12-02 |
Squamous Cell Carcinoma of Head and Neck (3)
Cytidine Triphosphate (1) · Inosine Triphosphate (1)
China (1)